Japan categorizes devices by risk level, clinical importance, & innovation. High-risk devices, like Class III & IV, undergo stricter scrutiny, requiring robust clinical evidence. The reimbursement classification determines if the device qualifies for existing pricing categories or if a new category & price need to be established.
